Impact of peripheral arterial disease on health status: A comparison with chronic heart failure

Smolderen, Kim G.; Pelle, Aline J.; Kupper, Nina; Mols, Floortje; Denollet, Johan

doi:10.1016/j.jvs.2009.07.109

Cited by 21 publications

(24 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…23 The SF‐12 has been demonstrated to be a valid and reliable instrument 20 and has been successfully utilized in PAD populations. 24–25 …”

Section: Methodsmentioning

confidence: 99%

“…23 The SF-12 has been demonstrated to be a valid and reliable instrument 20 and has been successfully utilized in PAD populations. 24,25 Depressive symptoms The 14-item self-report Hospital Anxiety and Depression Scale was used to measure self-reported depressive symptoms. Criterion scores of ≥8 for the depression subscale denote clinically relevant symptoms of depression.…”

Section: Health Statusmentioning

confidence: 99%

See 1 more Smart Citation

Gender Differences in Health Status and Adverse Outcomes Among Patients With Peripheral Arterial Disease

Dreyer¹,

Zitteren

Beltrame

et al. 2015

JAHA

Self Cite

View full text Add to dashboard Cite

BackgroundFew studies have examined gender differences in health status and cardiovascular outcomes in patients with peripheral artery disease (PAD). This study assessed (1) self‐reported health status at PAD diagnosis and 12‐months later, and explored (2) whether outcomes in women with PAD differ with regard to long‐term major adverse events.Methods and ResultsA total of 816 patients (285 women) with PAD were enrolled from 2 vascular clinics in the Netherlands. Baseline clinical data and subsequent adverse events were recorded and patients completed the Short Form‐12 (SF‐12, Physical Component Score [PCS] and Mental Component Score [MCS]) upon PAD diagnosis and 12‐months later. Women had similar ages and clinical characteristics, but poorer socio‐economic status and more depressive symptoms at initial diagnosis, as compared with men. Women also had poorer physical (PCS: 37±10 versus 40±10, P=0.004) and mental (MCS: 47±12 versus 49±11, P=0.005) health status at the time of presentation. At 12‐months, women still reported a poorer overall PCS score (41±12 versus 46±11, P=0.006) and MCS score (42±14 versus 49±12, P=0.002). Female gender was an independent determinant of a poorer baseline and 12‐month PCS and MCS scores. However, there were no significant differences by gender on either mortality (unadjusted hazard ratio [HR]=0.93, 95% CI 0.60;1.44, P=0.74) or major adverse events (unadjusted HR=0.90, 95% CI 0.63;1.29, P=0.57), after a median follow‐up of 3.2 years.ConclusionsWomen's physical and mental health status is compromised both at initial PAD diagnosis and at 12‐month follow‐up, despite experiencing a similar magnitude of change in their health scores throughout the first 12‐months after diagnosis.

show abstract

“…23 The SF‐12 has been demonstrated to be a valid and reliable instrument 20 and has been successfully utilized in PAD populations. 24–25 …”

Section: Methodsmentioning

confidence: 99%

Section: Health Statusmentioning

confidence: 99%

Gender Differences in Health Status and Adverse Outcomes Among Patients With Peripheral Arterial Disease

Dreyer¹,

Zitteren

Beltrame

et al. 2015

JAHA

Self Cite

View full text Add to dashboard Cite

show abstract

“…28 It was designed to be a simpler version of the SF-36, scored in the same way as the SF-36. Using the SF-12, Smolderen et al 29 assessed baseline HRQOL of symptomatic PAD patients compared to chronic heart failure patients. Results indicated that the physical domains were affected to a greater extent in PAD patients, whereas the mental domains were significantly worse in chronic heart failure patients.…”

Section: Functional Status/hrqol Questionnaires For Symptomatic Padmentioning

confidence: 99%

Assessment of functional status and quality of life in claudication

Mays

Casserly

Kohrt

et al. 2011

Journal of Vascular Surgery

View full text Add to dashboard Cite

Background Treadmill walking is commonly used to evaluate walking impairment and efficacy of treatment for intermittent claudication (IC) in clinical and research settings. Although this is an important measure, it does not provide information about how patients perceive the effects of their treatments on more global measures of health-related quality of life (HRQOL). Methods PubMed/Medline was searched to find publications about the most commonly used questionnaires to assess functional status and/or general and disease-specific HRQOL in patients with PAD who experience IC. Inclusion criteria for questionnaires were based on existence of a body of literature in symptomatic PAD. Results Six general questionnaires and 7 disease-specific questionnaires are included with details about the number of domains covered and how each tool is scored. The Medical Outcomes Study Short Form 36 item questionnaire and Walking Impairment Questionnaire are currently the most used general and disease-specific questionnaires at baseline and following treatment for IC, respectively. Conclusions The use of tools which assess functional status and HRQOL has importance in both the clinical and research areas to assess treatment efficacy from the patient perspective. Therefore, assessing HRQOL in addition to treadmill-measured walking ability provides insight as to effects of treatments on patient outcomes and may help guide therapy.

show abstract

“…12 Additionally, MCS scores in patients with a neuropathic component were comparable to scores in patients with severe chronic obstructive pulmonary disease and congestive heart failure. 13,14 The limitations of our study include the inherent bias associated with self-reported data. Patients presenting to the physician office complete surveys based on symptoms at the time of completion.…”

Section: S-lanss Scores In Patients Withmentioning

confidence: 97%